Expertise in
2
conditions

Sergey N. Skornyakov

50 XXII Partsyezda Street, 
Yekaterinburg, SVE, RU 
Expertise in
2
conditions
50 XXII Partsyezda Street, 
Yekaterinburg, SVE, RU 

Overview

Sergey Skornyakov practices practicing medicine in Yekaterinburg, Russian Federation.

Mr. Skornyakov is highly rated in 2 conditions, according to our data. His clinical expertise encompasses Pulmonary Tuberculosis and Pleurisy.

He is actively involved in clinical research, co-authoring 18 peer reviewed articles and participating in 1 clinical trial.

Gender

Male

Locations

50 XXII Partsyezda Street, Yekaterinburg, SVE 620039, Russian Federation

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Phase 3 Partially-blinded, Randomized Trial Assessing the Safety and Efficacy of Various Doses and Treatment Durations of Linezolid Plus Bedaquiline and Pretomanid in Participants With Pulmonary Infection of Either Extensively Drug-resistant Tuberculosis (XDR-TB), Pre-XDR-TB or Treatment Intolerant or Non-responsive Multi-drug Resistant Tuberculosis (MDR-TB)
A Phase 3 Partially-blinded, Randomized Trial Assessing the Safety and Efficacy of Various Doses and Treatment Durations of Linezolid Plus Bedaquiline and Pretomanid in Participants With Pulmonary Infection of Either Extensively Drug-resistant Tuberculosis (XDR-TB), Pre-XDR-TB or Treatment Intolerant or Non-responsive Multi-drug Resistant Tuberculosis (MDR-TB)
Enrollment Status: Completed
Publish Date: June 29, 2023
Intervention Type: Drug
Study Phase: Phase 3

18 Total Publications

Lesion-specific features of macrophage polarization contribute to Mycobacterium tuberculosis infection in the lungs of patients with pulmonary tuberculosis.
Lesion-specific features of macrophage polarization contribute to Mycobacterium tuberculosis infection in the lungs of patients with pulmonary tuberculosis.
Journal: Frontiers in immunology
Published: April 11, 2026

Frequently Asked Questions about Sergey N. Skornyakov

Is Sergey N. Skornyakov a top-rated expert for Pulmonary Tuberculosis?

MediFind is an objective health platform that identifies experts based on real-world data. Sergey N. Skornyakov is classified as an Distinguished expert for Pulmonary Tuberculosis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Sergey N. Skornyakov participate in research or clinical trials?

Yes. Sergey N. Skornyakov has published 18 articles and abstracts on conditions like Pulmonary Tuberculosis. You can view a list of Sergey N. Skornyakov's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Skornyakov's expertise for a condition
ConditionClose
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile